Understanding production and application of alpha emitting radionuclides. This project aims to develop new materials to improve the efficiency of production of radionuclides, as well as tools to improve our understanding of isotope decay products to to improve efficiency of delivery. High performance polymers will be evaluated to establish optimal design properties for enhanced radionuclide collection from novel generators of isotopic lead (Pb-212), and new methods will be developed to improve u ....Understanding production and application of alpha emitting radionuclides. This project aims to develop new materials to improve the efficiency of production of radionuclides, as well as tools to improve our understanding of isotope decay products to to improve efficiency of delivery. High performance polymers will be evaluated to establish optimal design properties for enhanced radionuclide collection from novel generators of isotopic lead (Pb-212), and new methods will be developed to improve understanding of isotope product stability. Anticipated outcomes will provide greater production and utility of radioisotopes in radiopharmaceuticals, while building strong ties with partner AdvanCell Isotopes. This could improve manufacture of radionuclides, expanding capability and applications in radiopharmaceuticals.Read moreRead less
Epitaxial Stacking of Nanoporous Nanosheets for Next-generation Membranes. The project aims to develop high-precision selective membranes which are urgently needed in Australian key industries for solute-solute separation by constructing vertically-aligned and chemically-tailorable nanochannels using two-dimensional porous nanosheets as building blocks. The project expects to generate advanced knowledge in the areas of nanosheet synthesis and functionalisation, membrane design and fabrication, s ....Epitaxial Stacking of Nanoporous Nanosheets for Next-generation Membranes. The project aims to develop high-precision selective membranes which are urgently needed in Australian key industries for solute-solute separation by constructing vertically-aligned and chemically-tailorable nanochannels using two-dimensional porous nanosheets as building blocks. The project expects to generate advanced knowledge in the areas of nanosheet synthesis and functionalisation, membrane design and fabrication, selective transport of solutes and applications. The membranes developed in the project should make existing separation processes more effective and sustainable and advance emerging applications in pharmaceutical, dairy and mining industries, providing significant economic and environmental benefits to Australia.Read moreRead less
Industrial biotechnology for improved manufacture of medicinal alkaloids. Industrial biotechnology for improved manufacture of medicinal alkaloids. This project aims to develop a new semi-synthetic route for the manufacture of Codeine from Thebaine. Codeine is manufactured by the chemical conversion of poppy-derived Morphine, which is low yielding and environmentally unfriendly. This project will investigate and optimise two key enzymes in the biosynthetic pathway to Codeine and develop an innov ....Industrial biotechnology for improved manufacture of medicinal alkaloids. Industrial biotechnology for improved manufacture of medicinal alkaloids. This project aims to develop a new semi-synthetic route for the manufacture of Codeine from Thebaine. Codeine is manufactured by the chemical conversion of poppy-derived Morphine, which is low yielding and environmentally unfriendly. This project will investigate and optimise two key enzymes in the biosynthetic pathway to Codeine and develop an innovative bioreactor to achieve high yield. It will research industrial biotransformations, providing a greener and cheaper process for increased global access to Codeine. Australian opiate manufacturing is expected to benefit from value adding and increased flexibility introduced by a biotechnology approach.Read moreRead less
A VAST potential for ion channel drug discovery. The purpose of this project is to bring innovation into the methods used for identifying and characterising novel carbohydrate-based compounds acting at ion channels. These molecules will have high potential to be developed as highly effective treatments for pain without the unpleasant side-effects associated with current treatments.
Efficacy profiling innovation in novel pain therapeutics discovery. The purpose of this project is to bring innovation into the methods used for selecting novel compounds with high potential for progression into development as highly effective pain-killers for improving the relief of chronic pain. This will result in new pain-killers that are highly effective without producing unpleasant side-effects.
Industrial Transformation Training Centres - Grant ID: IC180100021
Funder
Australian Research Council
Funding Amount
$4,163,359.00
Summary
ARC Training Centre for the Development of Tools for Fragment Based Design. The ARC Training Centre for the Development of Tools for Fragment Based Design aims to inspire the next generation of drug discovery research leaders. It plans to provide direct experience with industry partners, training and master classes in early stage drug-discovery from industry experts. The Centre is expected to accelerate research translation and industry engagement by providing an efficient strategy for the scree ....ARC Training Centre for the Development of Tools for Fragment Based Design. The ARC Training Centre for the Development of Tools for Fragment Based Design aims to inspire the next generation of drug discovery research leaders. It plans to provide direct experience with industry partners, training and master classes in early stage drug-discovery from industry experts. The Centre is expected to accelerate research translation and industry engagement by providing an efficient strategy for the screening of a biological target and early medicinal chemistry for optimisation. The expected outcome of the Centre is to equip the trainees with the skills to make key contributions to the sustainability and growth of the sector and to provide significant capacity to address global challenges for 21st century pharmaceutical innovation.Read moreRead less
Development of Liposaccharide Peptide Conjugates for Peptide Drug Delivery. We aim to adapt the Solid Phase Oligosaccharide Synthesis technology patented by Alchemia to develop methodologies that will allow the assembly of sugar, lipid and peptide units on a single solid phase resin. This synthetic technology will then be used to generate a library of liposaccharide conjugates of two model peptides (LHRH and TRH) to investigate and optimise a broadly applicable peptide drug delivery system whic ....Development of Liposaccharide Peptide Conjugates for Peptide Drug Delivery. We aim to adapt the Solid Phase Oligosaccharide Synthesis technology patented by Alchemia to develop methodologies that will allow the assembly of sugar, lipid and peptide units on a single solid phase resin. This synthetic technology will then be used to generate a library of liposaccharide conjugates of two model peptides (LHRH and TRH) to investigate and optimise a broadly applicable peptide drug delivery system which improves peptides oral absorption, metabolic stability and bioavailability.Read moreRead less
Industrial Transformation Research Hubs - Grant ID: IH220100017
Funder
Australian Research Council
Funding Amount
$4,808,669.00
Summary
ARC Research Hub for Advanced Manufacture of Targeted Radiopharmaceuticals. Radiopharmaceuticals are emerging as next generation medical technologies for addressing complex health challenges, and their manufacture offers significant economic benefit to Australia. The ARC Research Hub for Advanced Manufacture of Targeted Radiopharmaceuticals (AMTAR) aims to establish a manufacturing platform for new medical technologies combining innovations in biotechnology and pharmaceutical science. The progra ....ARC Research Hub for Advanced Manufacture of Targeted Radiopharmaceuticals. Radiopharmaceuticals are emerging as next generation medical technologies for addressing complex health challenges, and their manufacture offers significant economic benefit to Australia. The ARC Research Hub for Advanced Manufacture of Targeted Radiopharmaceuticals (AMTAR) aims to establish a manufacturing platform for new medical technologies combining innovations in biotechnology and pharmaceutical science. The program addresses industry-led challenges for translation of biologics as molecular radiopharmaceuticals, building capacity in biomanufacturing, radiobiology and radiochemistry. The program establishes a dedicated manufacturing pipeline, future-proofing production and securing supply chain of next generation medical technologies.Read moreRead less
CHARGED LIPOSACCHARIDE BASED DRUG DELIVERY SYSTEM. Complexation of a drug with lipid and/or sugar units represents one of the most important of the strategies being investigated in this burgeoning field. Increasing the lipid solubility of a hydrophilic compound has been established as an important factor in improving its absorption as it is necessary for passive transport across intestinal mucosal membranes. The role of sugar unit is very important: (i) it modifies the physico-chemical propertie ....CHARGED LIPOSACCHARIDE BASED DRUG DELIVERY SYSTEM. Complexation of a drug with lipid and/or sugar units represents one of the most important of the strategies being investigated in this burgeoning field. Increasing the lipid solubility of a hydrophilic compound has been established as an important factor in improving its absorption as it is necessary for passive transport across intestinal mucosal membranes. The role of sugar unit is very important: (i) it modifies the physico-chemical properties (solubility), (ii) utilizes active transport systems (e.g. Glucose transport) and (iii) target the compound - "MAGIC BULET" (Lewis X analogues - damaged cells). There is no limit to the areas of medicine and public health that would benefit from revolutionary new technology in these areas.Read moreRead less
Designing dendrimer-based lymphatic drug vectors as improved treatments for metastatic cancer. This project builds on areas of research strength in Australia (nanotechnology and biotechnology/biomaterials) and will add considerably to the expanding Australian expertise-base in dendrimer technology (in which it is a world leader). The project will advance the fundamental science base that underpins dendrimer design and has the potential to deliver substantial benefits in improved drug delivery an ....Designing dendrimer-based lymphatic drug vectors as improved treatments for metastatic cancer. This project builds on areas of research strength in Australia (nanotechnology and biotechnology/biomaterials) and will add considerably to the expanding Australian expertise-base in dendrimer technology (in which it is a world leader). The project will advance the fundamental science base that underpins dendrimer design and has the potential to deliver substantial benefits in improved drug delivery and therefore health outcomes for Australia. The interdisciplinary nature of this project will also result in a unique training program for the researchers involved. Such experience is in great demand in Australia where the developing biotechnology and nanotechnology industry is critically short of scientists with skills in drug delivery.Read moreRead less